Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season

Marianne A B van der Sande, Wilhelmina L M Ruijs, Adam Meijer, Herman J M Cools, Simone M van der Plas

Research output: Contribution to journalA1: Web of Science-article

Abstract

To assess the implementation of guidelines for using neuraminidase inhibitors in the control of influenza outbreaks in Dutch nursing homes, data were collected on prophylactic and therapeutic use of anti-viral medication, indications for use and criteria for prescribing, based on experiences during the influenza season 2004-2005 in a retrospective cross-sectional survey among Dutch nursing homes after the 2004-2005 season. Ninety/194 (49%) participating nursing homes reported an outbreak of influenza-like illness; in 57/194 (29%) influenza was laboratory confirmed. In 37/57 homes (65%) oseltamivir had been used as prophylaxis. Prophylactic use was extended to all residents and staff in 6/37 (16%) of homes, but limited in the others. In 9/37 (24%) no staff were issued prophylaxis. Among clinicians with laboratory confirmed influenza, 41/46 (89%) had used oseltamivir therapeutically. Main reasons for not prescribing oseltamivir for prophylaxis and/or therapy were lack of scientific evidence, high costs, and absent or delayed laboratory confirmation. Logistical bottlenecks in diagnosis, cost-effectiveness concerns, and lack of an evidence-base hamper full integration in policy and should be addressed.

Original languageEnglish
JournalVaccine
Volume24
Issue number44-46
Pages (from-to)6664-9
Number of pages6
ISSN0264-410X
DOIs
Publication statusPublished - 2006

Keywords

  • Antiviral Agents/therapeutic use
  • Disease Outbreaks/prevention & control
  • Female
  • Health Planning Guidelines
  • Humans
  • Influenza, Human/epidemiology
  • Male
  • Nursing Homes
  • Oseltamivir/therapeutic use
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Primary Prevention
  • Retrospective Studies

Fingerprint

Dive into the research topics of 'Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season'. Together they form a unique fingerprint.

Cite this